Lancet Neurol · Jan 2025
Read original source →Optimised medical therapy alone versus optimised medical therapy plus revascularisation for asymptomatic or low-to-intermediate risk symptomatic carotid stenosis (ECST-2): 2-year interim results of a multicentre randomised trial
European trial that also enrolled lower-risk symptomatic patients; interim analysis of a small sample; on-page only here in the family.
Highlights
Index entry — verify clinical detail against the primary source.
Related conditions
For learning and professional reference; not a patient-specific recommendation. How we prepare content.